Loading...
XLONNSCI
Market cap15mUSD
Oct 21, Last price  
52.50GBP
Name

Netscientific PLC

Chart & Performance

D1W1MN
XLON:NSCI chart
P/E
P/S
870.00
EPS
Div Yield, %
9.06%
Shrs. gr., 5y
25.41%
Rev. gr., 5y
42.61%
Revenues
1m
+43.92%
0000021,000518,000171,000245,000735,000394,0001,107,0001,004,0001,445,000
Net income
-3m
L-14.58%
-1,069,167-1,229,328-1,532,126-4,112,565-6,425,011-10,548,000-10,712,000-8,318,000-8,327,999-3,788,000-1,611,000-2,385,000-3,094,000-2,643,000
CFO
-3m
L+1.13%
-343,965-939,107-1,229,656-3,678,706-6,611,373-10,593,000-12,738,000-10,600,000-8,257,999-4,115,999-2,790,000-3,480,000-3,106,000-3,141,000
Earnings
May 07, 2025

Profile

NetScientific plc is a venture capital firm specializing in seed, early and mid stage investments. The firm focuses to invest in sustainability, technology, transformative biomedical and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases. Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets and in the United States. It typically invests up to £15 million ($20.32 million), but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries. The firm prefers to invest through its balance sheet investments. NetScientific plc was founded in 2008 and is based in London, United Kingdom.
IPO date
Sep 16, 2013
Employees
26
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,445
43.92%
1,004
-9.30%
1,107
180.96%
Cost of revenue
5,659
5,504
4,136
Unusual Expense (Income)
NOPBT
(4,214)
(4,500)
(3,029)
NOPBT Margin
Operating Taxes
3,138
(37)
(61)
Tax Rate
NOPAT
(7,352)
(4,463)
(2,968)
Net income
(2,643)
-14.58%
(3,094)
29.73%
(2,385)
48.04%
Dividends
(113,899)
Dividend yield
807.21%
Proceeds from repurchase of equity
21
1,502
7,309
BB yield
-0.15%
-8.38%
-40.90%
Debt
Debt current
770
267
91
Long-term debt
1,889
987
563
Deferred revenue
Other long-term liabilities
268
131
Net debt
(15,662)
(23,034)
(15,034)
Cash flow
Cash from operating activities
(3,141)
(3,106)
(3,480)
CAPEX
(366)
(53)
(62)
Cash from investing activities
1,112
(531)
(3,458)
Cash from financing activities
1,389
1,740
8,019
FCF
(532,959)
(3,726)
(3,081)
Balance
Cash
365
852
2,710
Long term investments
17,956
23,436
12,978
Excess cash
18,249
24,238
15,633
Stockholders' equity
(57,105)
(48,933)
(54,283)
Invested Capital
602,866
75,429
73,446
ROIC
ROCE
EV
Common stock shares outstanding
23,517
22,267
18,051
Price
0.60
-25.47%
0.81
-18.69%
0.99
112.90%
Market cap
14,110
-21.28%
17,925
0.30%
17,870
157.64%
EV
(2,272)
(5,707)
2,845
EBITDA
(3,752)
(4,153)
(2,781)
EV/EBITDA
0.61
1.37
Interest
171
55
22
Interest/NOPBT